Health Velocity Capital

Investment decisions are led by co-founders and managing partners Ursheet Parikh and Rylan Bowers. Parikh previously invested at NEA and Scale Venture Partners, while Bowers held a venture role at GE Ventures. The lean partnership structure means no investment committee filters exist beyond the two managing partners, an architecture designed for speed in competitive growth-stage processes.

The firm's core sourcing advantage stems from its strategic LP base, which includes senior executives at large health plans, health systems, and healthcare technology companies. These relationships provide early visibility into emerging companies solving operational pain points inside payer and provider organizations. The firm also leverages its portfolio-founder network and the healthcare CIO community that Bowers cultivated during his tenure at GE Ventures.

Health Velocity Capital is a growth-stage investor, typically leading Series B and C rounds. The firm looks for companies generating between $5 million and $20 million in revenue that have demonstrated product-market fit inside healthcare enterprises and need capital to scale commercial teams and expand into adjacent customer segments.

Unlike a traditional LP-GP arrangement, the firm's healthcare executive LPs serve as an informal advisory and commercial network. They provide market intelligence on procurement cycles, regulatory shifts, and competitive dynamics from inside payer and provider organizations. Several LPs have facilitated pilot programs and enterprise introductions for portfolio companies, though the firm publicly discloses no formal revenue-sharing or fee arrangements with its LP network.

The firm does not invest in therapeutics, medical devices, diagnostics, or biotech platforms. Its mandate explicitly excludes FDA-regulated clinical products and instead concentrates on software, data platforms, and tech-enabled service models that improve healthcare administration, payment, and consumer access without taking regulatory risk on clinical outcomes.